Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Opiant Pharmaceuticals Inc (NASDAQ:OPNT)

32.00
Delayed Data
As of Oct 20
 -3.49 / -9.83%
Today’s Change
5.00
Today|||52-Week Range
51.90
+470.41%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues1.1M13.5M18.1K3.8M
 
 
 
 
 
Depreciation And Amortization1.3K1.3K1.3K1.3K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses1.7M2.9M3.2M3.6M
 
 
 
 
 
Research And Development441.8K344.8K1.1M1.3M
 
 
 
 
 
Total Operating Expenses1.7M2.9M3.2M3.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-579.0K10.6M-3.2M200.0K
 
 
 
 
 
Interest Expense On Debt2.2K0.000.000.00
 
 
Other Expenses-19.4K11.0K25.2K1.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-600.6K10.6M-3.1M212.0K
 
 
 
 
 
Income Taxes0.000.000.00-550.0K
 
 
Net Income-600.6K10.6M-3.1M-338.0K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.0M2.0M2.0M2.0M
 
 
 
 
 
Shares To Calculate EPS Diluted2.0M2.2M2.0M2.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.30$4.91-$1.55-$0.17
 
 
 
 
 
EPS Diluted-$0.30$4.91-$1.55-$0.17